The Story Behind Vaccine Maker Gritstone's Ch. 11

By Emily Lever · November 5, 2024, 10:16 PM EST

Vaccine maker Gritstone bio Inc. hit Chapter 11 after a tightening investment market left it starved of the capital it needed to keep doing its research into preventative treatments for cancer,...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Bankruptcy Scorecard

Summary

A vaccine developer focused on preventative treatments for cancer and HIV filed for bankruptcy with plans to find a buyer in Chapter 11 that will continue its research.

Case Number

24-bk-12305

Judge

Karen Owens

Venue

U.S. Bankruptcy Court for the District of Delaware

Capital Structure

Total Liabilities:

$100 million to $500 million

View Full Scorecard

Documents

Related Sections

Case Information

Case Title

Gritstone bio, Inc.

Case Number

1:24-bk-12305

Court

Delaware

Nature of Suit

Date Filed

October 10, 2024

Recent Articles By Emily